Form 4 holding
10%+ Owner
Aerovate Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 1,287,858
- Estimated value
- $3,232,523
- Report date
- 28 Apr 2025
- Price
- $2.51
- Ownership
- Indirect
RA CAPITAL MANAGEMENT, L.P. - 10%+ Owner at Jade Biosciences, Inc.
Issuer-level insider activity
- Role
- 10%+ Owner
- Issuer ticker
- JBIO on Nasdaq
- Entity type
- Company
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by RA CAPITAL MANAGEMENT, L.P. since 26 Aug 2025
Reported holdings for RA CAPITAL MANAGEMENT, L.P. in Jade Biosciences, Inc.
Form 4 holding
10%+ Owner
Aerovate Therapeutics, Inc.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 12,500
- Estimated value
- $204,625
- Report date
- 05 Jun 2024
- Price
- $16.37
- Ownership
- Indirect
- Underlying class
- Common Stock
- Underlying amount
Transaction history for RA CAPITAL MANAGEMENT, L.P. in Jade Biosciences, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.